Page 3 - Devicetalks Boston News Today

Skin cancer detection technology developer DermaSensor announced that it appointed three new members to its leadership team.

Intuitive remains the dominant surgical robotics company, but companies ranging from Medtronic to Vicarious Surgical look to compete.

The company's innovative DermaSensor device could save lives with early skin cancer detection capabilities.

Like a Starbucks-goer expects the coffee to taste a certain way at any location, Daniel Hawkins wants that experience in the operating room.

MedTech Innovator today announced 50 medical device startups that were chosen to participate in the organization's accelerator program.

Top experts at Boston Scientific, Medtronic and Acutus Medical shared insights about pulsed-field ablation’s potential at DeviceTalks Boston.

We’d like to see engineers, entrepreneurs, manufacturers, researchers, and others contribute their lessons and experiences to our expanded DeviceTalks West event.SANTA CLARA, Calif.--(BUSINESS WIRE)--#medical--DeviceTalks West, returning from a three-year hiatus to the Santa Clara Convention Center on October 19-20,...

Put simply, the reason most people enter the medtech space is to make a big difference in the lives of patients.

Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says.

DermaSensor — the creator of a handheld device to quickly assess skin lesions for cancer risk — won top honors at DeviceTalks Boston.